Jan 30, 2009 - Santarus, Inc., a specialty pharmaceutical company, today announced that it has submitted a New Drug Application to the U.S. FDA for a new tablet formulation to add to its ZEGERID family of branded prescription pharmaceutical products.
The details can be read here.
No comments:
Post a Comment